Moxifloxacină Misom (Moxifloxacin Hydrochloride)

Moxifloxacin Hydrochloride, the active ingredient in Moxifloxacină Misom, is a fluoroquinolone antibiotic presented as a sterile ophthalmic solution for ocular use. It is employed to treat bacterial eye infections in adult patients.

GNH USA supplies Moxifloxacină Misom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide. The company adheres to EU quality standards and provides reliable distribution to healthcare institutions across multiple regions. Its portfolio includes a range of ophthalmic and systemic medicines, ensuring consistent availability for patient care.

Moxifloxacină Misom is a fluoroquinolone antibiotic used in the ocular pathway to manage bacterial eye infections. - Bacterial conjunctivitis: reduces bacterial load and accelerates symptom relief in acute conjunctival infection. - Bacterial keratitis: eradicates pathogenic bacteria in corneal ulcers, supporting healing and preventing scarring. - Post‑operative ocular prophylaxis: prevents bacterial contamination after intra‑ocular surgery such as cataract extraction.

Moxifloxacină Misom may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Eye irritation or burning sensation - Redness of the conjunctiva - Foreign body sensation - Transient blurred vision - Increased tearing - Mild eyelid edema

Serious or Rare Side Effects: - Allergic contact dermatitis of the eye - Corneal ulceration or perforation - Severe ocular pain - Vision loss - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Systemic hypersensitivity reactions

When prescribing Moxifloxacină Misom, clinicians should consider several safety precautions to minimize risk. - Pregnancy: safety not established; avoid unless the benefit outweighs the risk. - Breastfeeding: unknown excretion in milk; use with caution. - Hypersensitivity: do not use in patients with known allergy to fluoroquinolones or any component of the formulation. - Contact lens wearers: discontinue lens use during treatment to reduce irritation. - Concurrent ocular steroids: monitor closely as combined use may increase risk of corneal thinning. - Store at room temperature: keep in the original container, protect from light and moisture.

Moxifloxacină Misom can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase systemic exposure and risk of tendon or CNS toxicity. - Anticholinergic eye drops: may reduce ocular absorption of moxifloxacin, diminishing antibacterial effect.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: combined therapy can heighten the chance of corneal ulceration. - Non‑steroidal anti‑inflammatory eye drops: may alter corneal healing dynamics. - Antihistamine eye drops: could increase ocular dryness, exacerbating irritation.